Meeting of the Uniform Formulary Beneficiary Advisory Panel, 34356-34357 [2012-14093]
Download as PDF
<![CDATA[
34356
Federal Register / Vol. 77, No. 112 / Monday, June 11, 2012 / Notices
Dated: June 6, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
Number of Respondents: 26,068
(based on number of FY2011 students
and their supervisors).
Responses per Respondent: 1.
Average Burden Hours per
Respondent: .22579.
[FR Doc. 2012–14112 Filed 6–8–12; 8:45 am]
BILLING CODE 5001–06–P
srobinson on DSK4SPTVN1PROD with NOTICES
Defense Security Service & Other
Federal Government Personnel
Total Annual Burden Hours: 15,384.
Number of Respondents: 67,032
(based on number of FY2011 students
and their supervisors).
Responses per Respondent: 1.
Average Burden Hours per
Respondent: .22950.
Frequency: One time and/or on
occasion (e.g., when there is a request to
develop training, when a student has
completed a course, etc.)
SUPPLEMENTARY INFORMATION:
Summary of Information Collection
This effort will collect qualitative
information through needs assessments
and evaluations. Feedback will be used
as guidance for developing and
evaluating DSS security education,
training, and professionalization
programs.
Two information collection efforts are
required. Responses to both collections
are voluntary.
The needs assessment is conducted
prior to the development of training to
collect data that will, in turn, be used
to prescribe an appropriate course of
action in response to a compliance
requirement or to a performance
deficiency that has been identified.
Some of the collection questions are
uniform, while others are unique to the
type of product or service that is being
requested. We request information in
several areas, including: organizational
goals and desired performance, training
conditions, technological environment,
types of jobs and tasks, types of
programs needed, and target audience.
Evaluations are completed after a
course of action has been implemented
to collect data used to gather
information about: the unmet training
needs of the population served;
maintaining and/or improving the
course, job aid, or security event; and/
or the effectiveness of operations that
provide programs and activities
supporting the job performance of
security professionals.
Defense Security Service, Center for
Development of Security Excellence,
management, instructional systems
designers, and instructional, technical
and support staff responsible for the
design and development of security
products and services, will be the users
of the data collected from needs
assessments and evaluations.
VerDate Mar<15>2010
20:21 Jun 08, 2012
Jkt 226001
DEPARTMENT OF DEFENSE
Office of the Secretary
Meeting of the Uniform Formulary
Beneficiary Advisory Panel
Assistant Secretary of Defense
(Health Affairs), Department of Defense.
ACTION: Notice of meeting.
AGENCY:
Under the provisions of the
Federal Advisory Committee Act of
1972 (5 U.S.C. Appendix, as amended)
and the Government in the Sunshine
Act of 1976 (5 U.S.C. 552b, as amended)
the Department of Defense (DoD)
announces the following Federal
Advisory Committee Meeting of the
Uniform Formulary Beneficiary
Advisory Panel (hereafter referred to as
the Panel).
DATES: June 21, 2012, from 9:00 a.m.–
1:00 p.m.
ADDRESSES: Naval Heritage Center
Theater, 701 Pennsylvania Avenue,
NW., Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: CDR
Joseph Lawrence, DFO, Uniform
Formulary Beneficiary Advisory Panel,
4130 Stanley Road, Suite 208, Building
1000, San Antonio, TX 78234–6012.
Telephone: (210) 295–1271, Fax: (210)
295–2789. Email Address:
Baprequests@tma.osd.mil.
SUMMARY:
Purpose of
Meeting: The Panel will review and
comment on recommendations made to
the Director of TRICARE Management
Activity, by the Pharmacy and
Therapeutics Committee, regarding the
Uniform Formulary.
SUPPLEMENTARY INFORMATION:
Meeting Agenda
1. Sign-In.
2. Welcome and Opening Remarks.
3. Public Citizen Comments.
4. Scheduled Therapeutic Class
Reviews (Comments will follow each
agenda item).
a. Newer Sedative/Hypnotic Agents.
b. Tobacco Cessation Agents.
c. Designated Newly Approved
Drugs in Already-Reviewed Classes.
d. Pertinent Utilization
Management Issues.
5. Panel Discussions and Vote.
Meeting Accessibility: Pursuant to 5
U.S.C. 552b, as amended, and 41 CFR
102–3.140 through 102–3.165, and the
availability of space, this meeting is
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
open to the public. Seating is limited
and will be provided only to the first
220 people signing-in. All persons must
sign-in legibly.
Administrative Work Meeting: Prior to
the public meeting, the Panel will
conduct an Administrative Work
Meeting from 7:30 a.m. to 9:00 a.m. to
discuss administrative matters of the
Panel. The Administrative Work
Meeting will be held at the Naval
Heritage Center, 701 Pennsylvania
Avenue, NW., Washington, DC 20004.
Pursuant to 41 CFR 102–3.160, the
Administrative Work Meeting will be
closed to the public.
Written Statements: Pursuant to 41
CFR 102–3.105(j) and 102–3.140, the
public or interested organizations may
submit written statements to the
membership of the Panel at any time or
in response to the stated agenda of a
planned meeting. Written statements
should be submitted to the Panel’s
Designated Federal Officer (DFO). The
DFO’s contact information can be
obtained from the General Services
Administration’s Federal Advisory
Committee Act Database at https://
www.fido.gov/facadatabase/public.asp.
Written statements that do not pertain
to the scheduled meeting of the Panel
may be submitted at any time. However,
if individual comments pertain to a
specific topic being discussed at a
planned meeting, then these statements
must be submitted no later than 5
business days prior to the meeting in
question. The DFO will review all
submitted written statements and
provide copies to all the committee
members.
Public Comments: In addition to
written statements, the Panel will set
aside 1 hour for individuals or
interested groups to address the Panel.
To ensure consideration of their
comments, individuals and interested
groups should submit written
statements as outlined in this notice; but
if they still want to address the Panel,
then they will be afforded the
opportunity to register to address the
Panel. The Panel’s DFO will have a
‘‘Sign-Up Roster’’ available at the Panel
meeting for registration on a first-come,
first-serve basis. Those wishing to
address the Panel will be given no more
than 5 minutes to present their
comments, and at the end of the 1 hour
time period, no further public
comments will be accepted. Anyone
who signs-up to address the Panel, but
is unable to do so due to the time
limitation, may submit their comments
in writing; however, they must
understand that their written comments
may not be reviewed prior to the Panel’s
deliberation.
E:\FR\FM\11JNN1.SGM
11JNN1
Federal Register / Vol. 77, No. 112 / Monday, June 11, 2012 / Notices
To ensure timeliness of comments for
the official record, the Panel encourages
that individuals and interested groups
consider submitting written statements
instead of addressing the Panel. Due to
changing requirements beyond the
control of the Uniform Formulary
Beneficiary Advisory Panel or its
Designated Federal Officer, the Panel
was unable to process the Federal
Register notice for the June 21, 2012
meeting as required by 41 CFR 102–
3.150(a). Accordingly, the Advisory
Committee Management Officer for the
Department of Defense, pursuant to 41
CFR 102–3.150(b), waives the 15calendar day notification requirement.
Dated: June 6, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2012–14093 Filed 6–8–12; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Missile Defense Advisory Committee;
Notice of Closed Meeting
Missile Defense Agency (MDA),
Department of Defense.
ACTION: Notice of closed meeting.
AGENCY:
Under the provisions of the
Federal Advisory Committee Act of
1972 (5 U.S.C., Appendix, as amended)
and the Government in the Sunshine
Act of 1976 (5 U.S.C. 552b, as amended)
and 41 CFR 102–3.150, the Department
of Defense announces that the following
Federal advisory committee meeting of
the Missile Defense Advisory
Committee will take place.
DATES: Tuesday, June 12, 2012 through
Wednesday, June 13, 2012, from 8:00
a.m. to 6:00 p.m. (each day). Security
clearance and visit requests are required
for access.
ADDRESSES: Missile Defense Integration
and Operations Center, Schriever Air
Force Base, Colorado Springs, Colorado,
80912.
FOR FURTHER INFORMATION CONTACT: Mr.
David Bagnati, Designated Federal
Officer at MDAC@mda.mil, phone/voice
mail 571–231–8113, or mail at 5700
18th Street, Building 245, Fort Belvoir,
Virginia 22060–5573.
SUPPLEMENTARY INFORMATION:
Purpose of the Meeting: At this
meeting, the Committee will receive
classified information on the Army’s
role in space application for the Ballistic
Missile Defense System.
Agenda: Topics tentatively scheduled
for classified discussion include, but are
srobinson on DSK4SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
20:21 Jun 08, 2012
Jkt 226001
not limited to, a classified orientation of
current, programmed and under
development space capabilities at the
Missile Defense Integration and
Operations Center; classified
information on Command, Control,
Communication, Computers,
Intelligence, Surveillance and
Reconnaissance including, but not
limited to, Command and Control,
Battle Management, and
Communications; Precision Tracking
Space System; Space Tracing and
Surveillance System; and
Discrimination; an update on the
Ballistic Missile Defense System;
feedback on its assessment of the
Missile Defense Agency’s Directed
Energy Program; and feedback on its
recommendations on the National
Academy of Science Report on Ballistic
Missile Defense.
Meeting Accessibility: Pursuant to 5
U.S.C. 552b, as amended, and 41 CFR
102–3.155 the Missile Defense Agency
has determined that the meeting shall be
closed to the public. The Director,
Missile Defense Agency, in consultation
with the Missile Defense Agency Office
of General Counsel, has determined in
writing that the public interest requires
that all sessions of the committee’s
meeting will be closed to the public
because they will be concerned with
classified information and matters
covered by section 5 U.S.C. 552b(c)(1).
Committee’s Designated Federal
Officer: Mr. David Bagnati,
MDAC@mda.mil, phone/voice mail
571–231–8113, or mail at 5700 18th
Street, Building 245, Fort Belvoir,
Virginia 22060–5573.
Pursuant to 41 CFR 102–3.105(j) and
102–3.140, and section 10(a)(3) of the
Federal Advisory Committee Act of
1972, the public or interested
organizations may submit written
statements to the membership of the
Missile Defense Advisory Committee
about its mission and functions. Written
statements may be submitted at any
time or in response to the stated agenda
of a planned meeting of the Missile
Defense Advisory Committee.
All written statements shall be
submitted to the Designated Federal
Officer for the Missile Defense Advisory
Committee, in the following formats:
One hard copy with original signature
and one electronic copy via email
(acceptable file formats: Adobe Acrobat
PDF, MS Word or MS PowerPoint), and
this individual will ensure that the
written statements are provided to the
membership for their consideration.
Contact information for the Designated
Federal Officer is as stated in FOR
FURTHER INFORMATION CONTACT and can
also be obtained from the GSA’s Federal
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
34357
Advisory Committee Act Database—
https://www.fido.gov/facadatabase/
public.asp.
Statements being submitted in
response to the agenda mentioned in
this notice must be received by the
Designated Federal Officer at the
address listed at least five calendar days
prior to the meeting which is the subject
of this notice. Written statements
received after this date may not be
provided to or considered by the Missile
Defense Advisory Committee until its
next meeting. The Designated Federal
Officer will review all timely
submissions with the Missile Defense
Advisory Committee Chairperson and
ensure they are provided to all members
of the Missile Defense Advisory
Committee before the meeting that is the
subject of this notice.
Due to changing requirements beyond
the control of the Missile Defense
Advisory Committee or its Designated
Federal Officer, the Committee was
unable to process the Federal Register
notice for its June 12 through June 13,
2012 meeting as required by 41 CFR
102–3.150(a). Accordingly, the Advisory
Committee Management Officer for the
Department of Defense, pursuant to 41
CFR 102–3.150(b), waives the 15calendar day notification requirement.
Dated: June 6, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2012–14100 Filed 6–8–12; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DOD–2012–OS–0062]
Privacy Act of 1974; System of
Records
Defense Information Systems
Agency, DoD.
ACTION: Notice to alter a system of
records.
AGENCY:
The Defense Information
Systems Agency proposes to alter a
system of records in its existing
inventory of record systems subject to
the Privacy Act of 1974 (5 U.S.C. 552a),
as amended.
DATES: The proposed action will be
effective on July 11, 2012 unless
comments are received which result in
a contrary determination.
ADDRESSES: You may submit comments,
identified by docket number and title,
by any of the following methods:
SUMMARY:
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 77, Number 112 (Monday, June 11, 2012)]
[Notices]
[Pages 34356-34357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14093]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Meeting of the Uniform Formulary Beneficiary Advisory Panel
AGENCY: Assistant Secretary of Defense (Health Affairs), Department of
Defense.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Under the provisions of the Federal Advisory Committee Act of
1972 (5 U.S.C. Appendix, as amended) and the Government in the Sunshine
Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense (DoD)
announces the following Federal Advisory Committee Meeting of the
Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as
the Panel).
DATES: June 21, 2012, from 9:00 a.m.-1:00 p.m.
ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW.,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: CDR Joseph Lawrence, DFO, Uniform
Formulary Beneficiary Advisory Panel, 4130 Stanley Road, Suite 208,
Building 1000, San Antonio, TX 78234-6012. Telephone: (210) 295-1271,
Fax: (210) 295-2789. Email Address: Baprequests@tma.osd.mil.
SUPPLEMENTARY INFORMATION: Purpose of Meeting: The Panel will review
and comment on recommendations made to the Director of TRICARE
Management Activity, by the Pharmacy and Therapeutics Committee,
regarding the Uniform Formulary.
Meeting Agenda
1. Sign-In.
2. Welcome and Opening Remarks.
3. Public Citizen Comments.
4. Scheduled Therapeutic Class Reviews (Comments will follow each
agenda item).
a. Newer Sedative/Hypnotic Agents.
b. Tobacco Cessation Agents.
c. Designated Newly Approved Drugs in Already-Reviewed Classes.
d. Pertinent Utilization Management Issues.
5. Panel Discussions and Vote.
Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and
41 CFR 102-3.140 through 102-3.165, and the availability of space, this
meeting is open to the public. Seating is limited and will be provided
only to the first 220 people signing-in. All persons must sign-in
legibly.
Administrative Work Meeting: Prior to the public meeting, the Panel
will conduct an Administrative Work Meeting from 7:30 a.m. to 9:00 a.m.
to discuss administrative matters of the Panel. The Administrative Work
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania
Avenue, NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the
Administrative Work Meeting will be closed to the public.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140,
the public or interested organizations may submit written statements to
the membership of the Panel at any time or in response to the stated
agenda of a planned meeting. Written statements should be submitted to
the Panel's Designated Federal Officer (DFO). The DFO's contact
information can be obtained from the General Services Administration's
Federal Advisory Committee Act Database at https://www.fido.gov/facadatabase/public.asp.
Written statements that do not pertain to the scheduled meeting of
the Panel may be submitted at any time. However, if individual comments
pertain to a specific topic being discussed at a planned meeting, then
these statements must be submitted no later than 5 business days prior
to the meeting in question. The DFO will review all submitted written
statements and provide copies to all the committee members.
Public Comments: In addition to written statements, the Panel will
set aside 1 hour for individuals or interested groups to address the
Panel. To ensure consideration of their comments, individuals and
interested groups should submit written statements as outlined in this
notice; but if they still want to address the Panel, then they will be
afforded the opportunity to register to address the Panel. The Panel's
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for
registration on a first-come, first-serve basis. Those wishing to
address the Panel will be given no more than 5 minutes to present their
comments, and at the end of the 1 hour time period, no further public
comments will be accepted. Anyone who signs-up to address the Panel,
but is unable to do so due to the time limitation, may submit their
comments in writing; however, they must understand that their written
comments may not be reviewed prior to the Panel's deliberation.
[[Page 34357]]
To ensure timeliness of comments for the official record, the Panel
encourages that individuals and interested groups consider submitting
written statements instead of addressing the Panel. Due to changing
requirements beyond the control of the Uniform Formulary Beneficiary
Advisory Panel or its Designated Federal Officer, the Panel was unable
to process the Federal Register notice for the June 21, 2012 meeting as
required by 41 CFR 102-3.150(a). Accordingly, the Advisory Committee
Management Officer for the Department of Defense, pursuant to 41 CFR
102-3.150(b), waives the 15-calendar day notification requirement.
Dated: June 6, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2012-14093 Filed 6-8-12; 8:45 am]
BILLING CODE 5001-06-P
